(Q24245920)

title

Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria (English)

0 references

0 references

0 references

0 references

0 references

H M McIntosh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

14 May 2020

K L Jones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

19 October 2005

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

14 May 2020

page(s)

CD000386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

14 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

14 May 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000386.PUB2

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000386.PUB2

Antimalarial drug resistance and combination chemotherapy

21 January 2018

1 reference

12 December 2020

Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.

1 reference

12 December 2020

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

1 reference

12 December 2020

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

12 December 2020

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

1 reference

12 December 2020

Reporting of adverse drug reactions in randomised controlled trials - a systematic survey

1 reference

12 December 2020

Epidemiology of drug-resistant malaria

1 reference

12 December 2020

A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children

1 reference

12 December 2020

Sulfadoxine-pyrimethamine monotherapy in Tanzanian children gives rapid parasite clearance but slow fever clearance that is improved by chloroquine in combination therapy

1 reference

12 December 2020

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.

1 reference

12 December 2020

The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria

1 reference

12 December 2020

Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance

1 reference

12 December 2020

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

1 reference

12 December 2020

Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos

1 reference

12 December 2020

Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.

1 reference

12 December 2020

Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy

1 reference

12 December 2020

Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of Malaria

1 reference

12 December 2020

Therapeutic efficacy of 3 treatment protocols for non-complicated Plasmodium falciparum malaria, Antioquia, Colombia, 2002

1 reference

12 December 2020

Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria

1 reference

12 December 2020

The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda

1 reference

12 December 2020

Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children

1 reference

12 December 2020

Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda

1 reference

12 December 2020

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up

1 reference

12 December 2020

Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda.

1 reference

12 December 2020

The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.

1 reference

12 December 2020

A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan.

1 reference

12 December 2020

Comparison of sulfadoxine-pyrimethamine with and without chloroquine for uncomplicated malaria in Nigeria.

1 reference

12 December 2020

Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.

1 reference

12 December 2020

Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.

1 reference

12 December 2020

Randomisation to protect against selection bias in healthcare trials

1 reference

12 December 2020

Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique

1 reference

12 December 2020

Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.

1 reference

12 December 2020

Efficacy of amodiaquine, Fansidar and their combination in the treatment of chloroquine-resistant falciparum malaria

1 reference

12 December 2020

Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.

1 reference

12 December 2020

Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

How frequent are notified severe cutaneous adverse reactions to Fansidar?

1 reference

12 December 2020

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

12 December 2020

A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children

1 reference

12 December 2020

Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review

1 reference

12 December 2020

10.1002/14651858.CD000386.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532604&resulttype=core&format=json

14 May 2020

1 reference